Centessa Pharmaceuticals PLC (NASDAQ:CNTA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mary Lynne Hedley Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Bluebird bio Inc (Director · Sep 18, 2017 – Jun 20, 2018 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Tesaro Inc (President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past); Abraxis BioScience Inc (Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past) | Director · Since at least May 27, 2021 |
| Marella Thorell Other companies: Carisma Therapeutics, Inc. (Director · Since at least Jun 30, 2024); Seres Therapeutics, Inc. (EVP, Chief Financial Officer · Since at least Mar 25, 2024); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Evelo Biosciences, Inc. (Chief Financial Officer · Jul 13, 2022 – Nov 7, 2023 · Past); GRI Bio, Inc. (Director · Feb 9, 2021 – Dec 13, 2022 · Past) | Chief Accounting Officer · May 27, 2021 – Mar 21, 2022 · Past |
| Atlantic S a r l General Other companies: Liftoff Mobile, Inc. (Director · Since at least Jun 4, 2026); Seaport Therapeutics, Inc. (Director · Since at least May 4, 2026); Alkami Technology, Inc. (Director · Since at least Apr 13, 2021); HireRight Holdings Corp (Director · Nov 16, 2022 – Jun 28, 2024 · Past) | Director · Jun 22, 2023 – Jun 22, 2023 · Past |
| Samarth Kulkarni Other companies: Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Black Diamond Therapeutics, Inc. (CEO, CRISPR Therapeutics AG · Since at least Jan 29, 2020); CRISPR Therapeutics AG (Chief Executive Officer and Chairman of the Board · Since at least Oct 18, 2016); Repare Therapeutics Inc (Director · Jun 18, 2020 – Jun 17, 2024 · Past) | Director · Since at least May 27, 2021 |
| Arjun Goyal Other companies: JATT III Acquisition Corp (Director · Since at least Aug 25, 2026); JATT II Acquisition Corp (Director · Since at least Apr 16, 2026) | Director · Since at least May 27, 2021 |
| John J Crowley Other companies: Fusion Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2020 – Jun 4, 2024 · Past); Charles River Laboratories International, Inc. (SVP, Chief Accounting Officer · May 24, 2016 – Oct 1, 2016 · Past) | Chief Financial Officer · Since at least Jun 10, 2024 |
| Carol Stuckley Other companies: Epizyme Inc (Director · Nov 16, 2021 – Aug 12, 2022 · Past) | Director · Since at least May 27, 2021 |
| Gregory M Weinhoff Other companies: Sio Gene Therapies Inc (Principal Financial Officer · Apr 29, 2016 – Mar 15, 2018 · Past) | Chief Business Officer · Since at least May 27, 2021 |
| Karen M Anderson Other companies: Mimecast Limited (Chief Human Resources Officer · Jan 3, 2019 – May 19, 2022 · Past) | Chief People Officer · Since at least Nov 30, 2022 |
| Atlantic Cooperatief U A General | Director · Jun 22, 2023 – Jun 22, 2023 · Past |
| David M Chao | Chief Administrative Officer · Sep 30, 2023 – Mar 17, 2025 · Past |
| Harris Rotman | SVP Regulatory Affairs · Feb 1, 2024 – Feb 1, 2024 · Past |
| Iqbal J Hussain | Chief Legal Officer · Since at least May 27, 2021 |
| Raphael Deferiere | Chief Accounting Officer · Since at least May 27, 2025 |
| Tia L Bush | Chief Technology & Quality Ofc · Since at least Jul 1, 2022 |